Xhance Approval History
FDA Approved: Yes (First approved September 18, 2017)
Brand name: Xhance
Generic name: fluticasone propionate
Dosage form: Nasal Spray
Previous Name: OPN-375
Company: Optinose US, Inc.
Treatment for: Nasal Polyps
Xhance (fluticasone propionate) is a topical nasal corticosteroid indicated for the treatment of nasal polyps.
Development History and FDA Approval Process for Xhance
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.